Therefore, the objective of our study was to evaluate the value of high serum myostatin levels as a biomarker of rheumatoid cachexia and myopenia in women with RA and to assess whether the elevated serum levels of this myokine constitute a relevant risk factor for rheumatoid cachexia independent of other factors. The gene discussed is MSTN; the disease is rheumatoid arthritis.